1957
DOI: 10.1111/j.1749-6632.1957.tb40756.x
|View full text |Cite
|
Sign up to set email alerts
|

Lysergic Acid Diethylamide and Related Substances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

1957
1957
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 81 publications
(24 citation statements)
references
References 11 publications
1
23
0
Order By: Relevance
“…LSD acutely decreased PPI of the acoustic startle response, consistent with preclinical data and the Schmid et 15 sensorimotor deficits seen in schizophrenia. The present experimental human study may serve as an interface for the translation of preclinical research with hallucinogens to clinical research findings in patients with schizophrenia and vice versa.…”
Section: Autonomic and Endocrine Effectssupporting
confidence: 71%
See 1 more Smart Citation
“…LSD acutely decreased PPI of the acoustic startle response, consistent with preclinical data and the Schmid et 15 sensorimotor deficits seen in schizophrenia. The present experimental human study may serve as an interface for the translation of preclinical research with hallucinogens to clinical research findings in patients with schizophrenia and vice versa.…”
Section: Autonomic and Endocrine Effectssupporting
confidence: 71%
“…Despite LSD's widespread recreational use, no scientific pharmacological studies have been conducted with LSD in the last 40 years. After the initial psychiatric investigation by Stoll (14), several case reports and studies in the 1950s and 1960s described aspects of the psychological effects of LSD (5,(15)(16)(17). However, these studies were not performed according to today's research standards and did not include control conditions or the systematic characterization of psychotropic effects.…”
Section: Introductionmentioning
confidence: 99%
“…The 5-hydroxytryptamine-like activity of some of these compounds has been emphasized (Shaw & Woolley, 1956), and, since the structureactivity relationships of tryptamine derivatives vary from tissue to tissue (see Erspamer, 1952;Barlow & Khan, 1959a, 1959b, 1959cVane, 1959;Greenberg, 1960;Hill & Usherwood, 1961), it is important that the site of the actual receptor involved should be specified when discussing these relationships (see Woolley, 1959;Gyermek, 1961). The failure of 2-bromo-( + )-lysergic acid diethylamide to reproduce the psychic manifestations which follow the administration of lysergic acid diethylamide (Cerletti & Rothlin, 1955), in spite of the observation that both-compounds effectively block the action of 5-hydroxytryptamine upon smooth muscle, was considered to be convincing evidence that the symptoms were not directly associated with a blocking of a central action of 5-hydroxytryptamine (see Gaddum & Vogt, 1956;Rothlin, 1957 ;Vogt, 1958). Other actions of 5-hydroxytryptamine analogues were envisaged (see Woolley, 1958), but these were still concerned with a possible role of 5-hydroxytryptamine as a neurohumoral agent.…”
Section: Discussionmentioning
confidence: 99%
“…One of these compounds is 2-bromo-lysergic acid diethylamide; this has 1.5 times the antiserotonin activity of lysergic acid diethylamide, and through this property, its presence in the brain, after systemic administration, can be demonstrated, but in doses more than 15 times as great it produces none of the mental effects of lysergic acid diethylamide (46). A recent report that, at least in one preparation, lysergic acid diethylamide in low concentration behaves like serotonin and does iiot antagonize it (47) seems to reconcile some of the empirical inconsistencies in the field, although it is quite at odds with the original hypotheses based on the antagonistic action of lysergic acid diethylamide.…”
Section: Serotoninmentioning
confidence: 97%